Please assess the completion status of the following clinical trial:

Trial Title: Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Homeless or marginally housed~* Score of greater than 13 on the Beck Depression Inventory (BDI)~* DSM-IV diagnosis of major depressive disorder, dysthymia, or minor depressive disorder~* Considered by the reviewing psychiatrist to benefit from antidepressant therapy~* Willing to take antidepressant medication or, if currently taking medication, willing to change medications if deemed appropriate~* Consents to coordinate with the primary medical provider~* Speaks English~Exclusion Criteria:~* Signs and symptoms consistent with diagnosis of dementia, as defined by DSM-IV~* Current substance abuse disorder requiring immediate residential or inpatient treatment~* At risk for suicide~* Presence of signs and symptoms consistent with psychotic depression, as defined by DSM-IV, warranting immediate hospitalization~* Any condition or use of any medication that may make simultaneous use of antidepressant medication unsafe~* Currently prescribed antidepressant therapy and in psychiatric treatment (treated by a psychiatrist within 3 months prior to study entry)~* Pregnant~* Bipolar disorder~* Current psychotic disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Participants receiving storefront directly observed therapy of anti-depressants (Fluoxetine)
- Control (Type: NO_INTERVENTION): Participants receiving referral to mental health follow-up with the UCSF AIDS Health Project

Based on this trial design, predict the completion outcome and termination type (if applicable).